Percheron Therapeutics Ltd - Company Profile

Powered by

All the sales intelligence you need on Percheron Therapeutics Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Percheron Therapeutics Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Percheron Therapeutics Ltd.

Back to companies

Percheron Therapeutics Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Percheron Therapeutics Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Percheron Therapeutics Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

James Garner

Chief Executive Officer; Managing Director Senior Management Since: 2023

Mr. James Garner has been the Chief Executive Officer and Managing Director of the company since 2023. Prior to this, he served as the Chief Executive Officer of Kazia Therapeutics Limited. Mr. James has held various leadership roles at Sanofi, Takeda Development Center Asia Pte Ltd, Quintiles, and Progen Pharmaceuticals Limited.

Read Hide full bio of James Garner

Deborah Ambrosini

Secretary; Chief Financial Officer Senior Management Since: 2024

Ms. Deborah Ambrosini has been the Chief Financial Officer and Secretary of the company since 2024. Prior to this, she served as the Chief Financial Officer of Cann Group and Acrux.

Read Hide full bio of Deborah Ambrosini

Valentina Dubljevic

Chief Technology Officer Senior Management Since: 2025

Ms. Valentina Dubljevic has been the Chief Technology Officer of the company since September 2025. Prior to this, she served as the Vice President of Scientific and Clinical Development at Patrys Ltd.

Read Hide full bio of Valentina Dubljevic

Eugene Kennedy

Chief Medical Officer Senior Management Since: 2025

Mr. Eugene Kennedy has been the Chief Medical Officer of the company since September 2025. Prior to this, he served as the Chief Medical Officer of Carisma Therapeutics.

Read Hide full bio of Eugene Kennedy

Charmaine Gittleson, M.D.

Chairperson Non Executive Board Since: 2021

Dr. Charmaine Gittleson has been the Chairperson of the company since 2021. Prior to this, she held various leadership roles including Senior Director, Head Safety and Clinical Development (2006-2010) in Melbourne Australia; Vice President of Clinical Strategy (2010-2013) and Senior Vice President of Clinical Development (2013-2017) in Pennsylvania United States.

Read Hide full bio of Charmaine Gittleson, M.D.
Gain a 360-degree view of Percheron Therapeutics Ltd and make more informed decisions for your business Gain a 360-degree view of Percheron Therapeutics Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer